The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.

A new FDA-approved weight-loss pill offers an alternative for patients who prefer not to use injectable medications.

Variety's writers pick the 50 best concerts of 2025, including Beyonce, David Byrne, Lady Gaga, Kendrick Lamar and SZA, Paul ...

LONDON, Dec 23 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying consumer market, with plans ...

As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity meds, a new report shows one taking a clear lead among potential prescribers. Spherix Global Insights ...

This is read by an automated voice. Please report any issues or inconsistencies here. Carl Carlton, the funk and R&B singer known for upbeat, era-embodying singles like “Everlasting Love” and “She’s a ...

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up a year ago, was hit with a warning letter from the FDA last month. The ...

When Novo Nordisk launched Wegovy, its pioneering weight-loss jab, in America in June 2021, it felt like it was “running into a dark tunnel”, recalls Maziar Mike Doustdar, who took over as the Danish ...

The premise of only picking a single stock from a small group of options obviously doesn't apply in the real world. You can ...

U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s NOVO.B-0.40%decrease; red down pointing triangle Ozempic and Wegovy—ushering in a new era of the ...

FDA approves Novo Nordisk's weight-loss pill Novo aims to regain market share from Eli Lilly Pill broadens potential patient pool The pill is 25 milligrams of semaglutide, the same active ingredient ...